The locally developed Medigen COVID-19 vaccine has successfully completed a phase 3 clinical trial in Paraguay and received emergency use authorization (EUA) from the South American nation.
The Taiwanese vaccine manufactured by Medigen Vaccine Biologics Corp (高端疫苗) was hailed by Taiwanese experts as an important milestone for domestically produced vaccines.
Medigen’s vaccine has been gaining recognition from international institutions. It has been included in the WHO’s Solidarity Trial Vaccines program and received a US$2.3 million grant from the Coalition for Epidemic Preparedness Innovations to conduct a mix-and-match trial.
Photo: CNA
A double-blind, randomized study was used in the clinical trial in Paraguay to compare Medigen’s vaccine with that made by AstraZeneca, Taiwan Immunization Vision and Strategy (台灣疫苗推動協會) chairman Huang Yu-cheng (黃玉成) said.
The results of the trial were similar to data collected from the phase 2 trial conducted in Taiwan.
Infectious-disease expert Lee Ping-ing (李秉穎) said that he was not surprised by the results and believes that Medigen’s vaccine would be approved by more nations.
Lee said that he hoped Taiwanese vaccines would no longer be politicized, but be generally accepted by Taiwanese.
Medigen is now waiting for the results of the WHO’s Solidarity Trial Vaccines clinical study, which evaluates the effectiveness of vaccines from around the world.
If the trial proceeds as scheduled, the results are expected by the end of next month or in early April, Medigen chief executive officer Charles Chen (陳燦堅) said.
The company already has capacity to manufacture more than 100 million doses in preparation for a shift from domestic to international markets, he said.
The pandemic has offered an opportunity for domestic manufacturers to develop vaccines and for Academia Sinica to improve its mRNA-related technologies, Huang said.
The experience gained and the growth in research and development would hopefully lead to quicker responses to future pandemics, he said.
Additional reporting by CNA
NEXT GENERATION: The four plants in the Central Taiwan Science Park, designated Fab 25, would consist of four 1.4-nanometer wafer manufacturing plants, TSMC said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) plans to begin construction of four new plants later this year, with the aim to officially launch production of 2-nanometer semiconductor wafers by late 2028, Central Taiwan Science Park Bureau director-general Hsu Maw-shin (許茂新) said. Hsu made the announcement at an event on Friday evening celebrating the Central Taiwan Science Park’s 22nd anniversary. The second phase of the park’s expansion would commence with the initial construction of water detention ponds and other structures aimed at soil and water conservation, Hsu said. TSMC has officially leased the land, with the Central Taiwan Science Park having handed over the
AUKUS: The Australian Ambassador to the US said his country is working with the Pentagon and he is confident that submarine issues will be resolved Australian Ambassador to the US Kevin Rudd on Friday said that if Taiwan were to fall to China’s occupation, it would unleash China’s military capacities and capabilities more broadly. He also said his country is working with the Pentagon on the US Department of Defense’s review of the AUKUS submarine project and is confident that all issues raised will be resolved. Rudd, who served as Australian prime minister from 2007 to 2010 and for three months in 2013, made the remarks at the Aspen Security Forum in Colorado and stressed the longstanding US-Australia alliance and his close relationship with the US Undersecretary
‘WORLD WAR III’: Republican Representative Marjorie Taylor Greene said the aid would inflame tensions, but her amendment was rejected 421 votes against six The US House of Representatives on Friday passed the Department of Defense Appropriations Act for fiscal 2026, which includes US$500 million for Taiwan. The bill, which totals US$831.5 billion in discretionary spending, passed in a 221-209 vote. According to the bill, the funds for Taiwan would be administered by the US Defense Security Cooperation Agency and would remain available through Sept. 30, 2027, for the Taiwan Security Cooperation Initiative. The legislation authorizes the US Secretary of Defense, with the agreement of the US Secretary of State, to use the funds to assist Taiwan in procuring defense articles and services, and military training. Republican Representative
TAIWAN IS TAIWAN: US Representative Tom Tiffany said the amendment was not controversial, as ‘Taiwan is not — nor has it ever been — part of Communist China’ The US House of Representatives on Friday passed an amendment banning the US Department of Defense from creating, buying or displaying any map that shows Taiwan as part of the People’s Republic of China (PRC). The “Honest Maps” amendment was approved in a voice vote on Friday as part of the Department of Defense Appropriations Act for the 2026 fiscal year. The amendment prohibits using any funds from the act to create, buy or display maps that show Taiwan, Kinmen, Matsu, Penghu, Wuciou (烏坵), Green Island (綠島) or Orchid Island (Lanyu, 蘭嶼) as part of the PRC. The act includes US$831.5 billion in
RSS